#QuolHoldings

On April 1, 2026, an establishment of a headquarters structure by integrating the Pharmacy Business, BPO Business, and Pharmaceutical Business segments, along with multiple executive personnel changes, will be implemented.

Revenue was 216,025 million yen (9.0% YoY increase), and net income attributable to owners of parent for the quarter was 4,671 million yen (32.6% YoY increase), marking a record high since establishment.